Sort
261,768 grants matching “gene therapy”
Genotypic Determinants of Aspirin Response in High-Risk
$3,980,607Johns Hopkins University · U01 · FY2003 · HL
Alzheimer's Disease Genetics Consortium
$3,980,408Gerard David Schellenberg · University Of Pennsylvania · U01 · FY2023 · AG
SPIROMICS II: Biological underpinnings of COPD heterogeneity and progression
$3,976,480Prescott G Woodruff · University Of California, San Francisco · U01 · FY2020 · HL
Chronic Lymphocytic Leukemia Research Consortium
$3,970,539Thomas J. Kipps · University Of California, San Diego · P01 · FY2009 · CA
A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease
$3,970,523Stacey Lynn Clardy · University Of Utah · U01 · FY2022 · NS
A Treatment for Patients with Jansens Metaphyseal Chondrodysplasia (JMC)
$3,966,484Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR
Alzheimer's Disease Genetics Consortium
$3,964,393Gerard David Schellenberg · University Of Pennsylvania · U01 · FY2024 · AG
The UCSC Genome Browser
$3,962,347Maximilian Haeussler · University Of California Santa Cruz · U24 · FY2023 · HG
Roswell Park Cancer Institute Center Support Grant
$3,960,459Donald L Trump · Roswell Park Cancer Institute Corp · P30 · FY2012 · CA
Myeloproliferative Neoplasms-Research Consortium
$3,957,858Ronald Hoffman · Icahn School Of Medicine At Mount Sinai · P01 · FY2025 · CA
Chronic Lymphocytic Leukemia Research Consortium
$3,956,000Thomas J. Kipps · University Of California, San Diego · P01 · FY2006 · CA
Innovative Approaches to Expand Cancer Genetic Screening and Testing for Patients & Families in a Statewide Oncology Network through Community, State, & Payer Partnerships
$3,955,535Elena Martinez Stoffel · University Of Michigan At Ann Arbor · U01 · FY2020 · CA
GCC Genomic Characterization Centers
$3,953,948David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2017 · CA
Mechanisms of Exosome Driven Immunoregulation of Cancer Progression
$3,950,956Robert H Blelloch · University Of California, San Francisco · U01 · FY2019 · CA
Multispecific targeting incorporating cytokine receptor pathways in high risk pediatric acute leukemias to improve durability of adoptive cell therapy-induced remissions
$3,950,741Terry J. Fry · University Of Colorado Denver · U01 · FY2018 · CA
The effects of Alzheimer's disease risk genes on metabolism and signaling across cell types
$3,944,334Ernest Fraenkel · Massachusetts Institute Of Technology · RF1 · FY2022 · AG
Targeting a lipid-mediated pro-longevity pathway as Alzheimer's therapy
$3,942,988Hui Zheng · Baylor College Of Medicine · RF1 · FY2018 · AG
Mechanisms, modeling and therapies of retinal and macular neurodegeneration
$3,937,795Anand Swaroop · National Eye Institute · ZIA · FY2024 · EY
MPN Research Consortium
$3,937,342Ronald Hoffman · Icahn School Of Medicine At Mount Sinai · P01 · FY2018 · CA
GENERAL CLINICAL RESEARCH CENTER
$3,931,928Mount Sinai School Of Medicine Of Nyu · M01 · FY2000 · RR
Cancer Center Support Grant
$3,929,093John David Carpten · Beckman Research Institute/City Of Hope · P30 · FY2025 · CA
Cancer Center Support Grant
$3,929,093John David Carpten · Beckman Research Institute/City Of Hope · P30 · FY2024 · CA
Development of novel therapies for FAD
$3,927,945Jie Shen · Brigham And Women'S Hospital · RF1 · FY2019 · AG
Core Support for Cancer Research Center
$3,927,789Albert Einstein Col Of Med Yeshiva Univ · P30 · FY2004 · CA
SOUTHWEST REGIONAL PRIMATE RESEARCH CENTER
$3,922,875Southwest Foundation For Biomedical Res · P51 · FY2002 · RR